Abstract
Recent information concerning the cell biology of leukemias has provided new insights into the pathophysiology and pathogenesis of acute leukemia, involving the detection of leukemia viruses, oncogenes and their products, and the discovery of factors supporting clonal leukemic growth. Murine, avian, and cat leukemia viruses are well characterized. To date, only HTLV I appears to be a likely candidate as a human leukemia virus. For both avian and murine viruses, there is a fundamental classification distinction between long-latency viruses (LLV) and acute transforming viruses (ATV). The ATV are replication defective and must be propagated with a helper virus. They have within their genome an identifiable oncogene. The LLV do not contain such an oncogene and presumably act by “promotor insertion”, e.g., a retroviral long terminal repeat (LTR inserted 5’ to the cellular oncogene. Acutely appearing neoplasms are probably not clonal, but reflect infection of multiple target cells. Long-latency neoplasms, however, are clonal and probably reflect expansion of a random oncogenic event. There are usually differences between in vitro and in vivo target cell specificities for these viruses. Furthermore, pathogenicity in the animal is greatly affected by animal age, inoculum route, and the genetics of the recipients. Target cell specificities will hopefully be classified by new in vitro culture techniques for hematopoietic cells. Three avian ATV are interesting because of their apparent target cell specificity:
AEV (erythroblastosis virus), AMV (myeloblastosis virus), and MC 29 (myelocytomatosis virus). Relative numbers of target cells appear to differ for these viruses: 50 for AEV, 700 for AMV, and 3500 for MC 29. AEV (V-erb B) affects erythroid precursors (presumably BFU-E), AMV (Vmyb), early myeloid precursors, and MC 29 (V-myc), macrophage-like cells. In vitro AEV and MC 29, but not AMV, transform fibroblasts.
Preview
Unable to display preview. Download preview PDF.
References
Ymer S, Tucker WOJ, Sanderson CJ, Hapel AJ, Campbell HD, Young IG (1985) Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI 3B is due to retroviral insertion near the gene. Nature 317: 255
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fms prto- oncogene product is related to the receptor for the mono nuclear phagocyte growth factor, CSF-1. Cell 41: 665
Moore MAS, Williams N, Metcalf D (1973) In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst 50: 603
Löwenberg B, Swart K, Hagemeijer A (1980) PHA-induced colony formation in acute nonlymphocytic and chronic myeloid leukemia. Leuk Res 4: 143
Minden MD, Till JE, McCulloch EA (1978) Proliferative state of blast cell progenitors in acute myeloblastic leukemia ( AML ). Blood 52: 592
Griffin JD, Herrmann F, Wiper D, Sabbath KD (1986) Effects of recombinant GM-CSF on clonogenic cells in acute myeloid leukemia. Blood 66: 1448
Herrmann F, Oster W, Lindemann A, Ganser A, Dörken B, Knapp W, Griffin JD, Mertelsmann R (1986) Leukemic-colony-forming in acute myeloblastic leukemia: maturation, hierarchy, and growth conditions. In: Neth R, Gallo RC (eds) Modern trends in leukemia, Vol 7. Springer, Berlin Heidelberg New York Tokyo (to be published)
Herrmann F, Cannistra SA, Griffin JD (1986) T cell-monocyte interactions in the production of humoral factors regulating human granulopoieses in vitro. J Immunol 136: 2856
Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, FREI III E (1980) treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303: 473
Vowels MR, White L, Hughes D (1985) Results of a pilot study for the treatment of childhood acute nonlymphoblastic leukemia. Cancer 55: 2337
Glucksberg H, Cheever MA, Farewell VT, Fefer A, Thomas ED (1983) Intensification therapy for acute non-lymphocyte leukemia in adults. Cancer 52: 198
Holmes R, Keating Mi, Cork A, Broach Y, Trujillo J., Dalton Jr, WT, McCredie KB, Freireich EJ (1985) A unique pattern of central nervous system leukemia in acute myelomyelomonocytic leukemia associated with inv(16) (p13q22). Blood 65: 1071
Wolff SN, Marion J, Stein RS, Flexner JM, Lazarms HM, Spitzer TR, Phillips GL, Herzig RH, Herzig GP (1985) High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: A pilot study. Blood 65: 1407
Brincker H (1985) Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission. Cancer Treat Rep 69: 5
Spriggs D, Griffin JD, Wisch J, Kufe D (1985) Clinical pharmacology of low-dose cytosine arabinoside. Blood 65: 1087
Burnett AK, Watkins R, Maharaj D, McKinnon S, Tansey P, Alcorn M, Singer CRJ, McDonald GR, Robertson AG (1984) Transplantation of un-purged autologous bone marrow in acute myeloid leukemia in first remission. Lancet II: 1068
Löwenberg B, Hagenbeek A, Sizoo W, De Gast GC, Verdonck LF (1984) Bone marrow transplantation studies in acute leukaemia. Lancet 11: 1400
Casellas P, Canat X, Fauser AA, Gros O, Laurent G, Poncelet P, Jansen FK (1985) Optimal elimination of leukemic T cells from human bone marrow with T 101-Ricin A-chain immunotoxin. Blood 65: 289
De Fabritiis P. Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Körbling M, Ritz J, Bast RC (1985) Elimination of clono-genic Burkitt’s lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 65: 1064
Uckun FM, Ramakrishnan S, Haag D, Houston LL (1985) Ex vivo elimination of lymphoblastic leukemia cells from human marrow by mafosfamid. Leuk Res 9: 83
Kaizer H, Stuart RK, Brookmeyer R, Beschorner WE, Braine JG, Burns WH, Fuller DJ, Körbling M, Mangan KF, Saral R, Sensenbrenner L, Shadduck RK, Shende AC, Tutschka P, Yeager AM, Zinkham WH, Colvin OM, Santos GW (1985) Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65: 1504
Bos JL, Toksoz D, Marshall CJ, Verlaan-De Vries M, Veenemann GH, Van Der Erb AJ, Van Boom JH, Janssen JWG, Steenvoorden ACM (1985) Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 315: 726
Hapel AJ, Fung MC, Johnson RM, Young IG, Johnson G, Metcalf D (1985) Biological properties of molecularly cloned and expressed murine interleukin-3. Blood 65: 1453
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mertelsmann, R.H., Herrmann, F. (1987). Acute Nonlymphocytic Leukemia in Adults: Pathophysiology, Status of Current Therapy, and New Approaches. In: Büchner, T., Schellong, G., Hiddemann, W., Urbanitz, D., Ritter, J. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71213-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-71213-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16556-9
Online ISBN: 978-3-642-71213-5
eBook Packages: Springer Book Archive